No Data
No Data
Tesla Bull Cathie Wood's Ark Invest Sells $7.16M Worth Of EV Maker's Shares After Q2 Earnings Reveal Profits Tanked Sharply
Canaccord Genuity Adjusts Price Target on 10x Genomics to $32 From $50, Maintains Buy Rating
10x Genomics Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on 10x Genomics, Lowers Price Target to $32
CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Cuts Target Price to $32
Express News | 10X Genomics Inc : Canaccord Genuity Cuts Target Price to $32 From $50
123456FEDCBA : why?
ForeverBean OP 123456FEDCBA : A friend of mine knows members of the management team and speaks highly of their capabilities--that's all. I personally value the quality of management a lot when investing. So the cheaper it gets, the more I'm willing to buy.
ForeverBean OP 123456FEDCBA : But still, it's highly personal. So please don't take my words seriously. It's for long-term.
123456FEDCBA : Cool, thanks for sharing